近期發(fā)表的論文
[1] Hou JM , Tian L ,Wei YQ, et al. Cancer immunotherapy of targeting angiogenesis. Cellular & molecular immunology, 2004,1(3)
[2] Tan GH, Tian L ,Wei YQ,et al. Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergist.INTERNATIONAL JOURNAL OF CANCER, 2004,112(4)
[3] Hou JM, Tian L, Wei YQ, et al. Immunotherapy of tumor by targeting angiogenesis.中國(guó)科學(xué) C, 2004,47(6)
[4] Tan GH, Wei YQ, Tian L, Yang L, et al. Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004,34(7)
[5] Li Q,Wei YQ,,Tian L,et al.Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcita.INTERNATIONAL JOURNAL OF CANCER, 2004,112(1)
[6] Lu Y, Wei YQ, Tian L, et al. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. J Immunol, 2003,170(6)
[7] Xie K, Tian L, Deng HX, Wei YQ, et al. Advances in identification and application of tumor antigen inducing anti-cancer responses.Chinese Sci Bull, 2003,48(11)
[8] Liu JY, Wei YQ ,Yang L, et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood, 2003,105(5)
[9] Su JM,Wei YQ,Tian L, et al. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. CANCER RESEARCH, 2003,63(3)
[10] He QM, Wei YQ, Tian L, et al. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem, 2003,278(24)
[11] Wei YQ, et al. Immunotherapy of tumors with vaccines based on xenogeneic homologous molecules. Anti Cancer Drugs, 2002,13(3)
[12] Xiao F, Wei YQ, Yang L, et al. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Therapy, 2002,2002(9)
[13] Liu T, Wei YQ, Liu T, et al.Construction of a recombinant protein vaccine based on xenopus homologous vascular endothelial growth factor(VEGF) and its antitumor efficacy. Blood, 2002,100(11)
[14] Lou YY, Wei YQ, Yang L, et al. Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin β3. Immunological Investigations, 2002,31(1)
[15] Peng F, Wei YQ, Tian L, et al. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol, 2002,2002(128)
[16] Wei YQ, et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci U S A, 2001,98(20)
[17] Tian L, Wei YQ, et al. Xenogeneic homologous genes, molecular evolution and cancer therapy. Progress in Natural Science, 2001,11(12)
[18] Wei YQ, Xia Y, Li Y, et al. Immunotherapy of turmous with xenogenetic endothelial cells as vaccine. Nature Medicine, 2000,6(10)
[19] 魏于全,田聆.異種同源基因
gydjdsj.org.cn、分子進(jìn)化與腫瘤治療.自然科學(xué)進(jìn)展, 2002,12(2)
聯(lián)系方式:
電話： 028-85422564 郵箱:yuquawei@vip.sina.com
上一頁(yè) [1] [2] [3] 下一頁(yè)
